SpineFrontier received clearance from the U.S. Food and Drug Administration to develop and produce a new cervical spine implant — the Arena-C HA — which will be manufactured with PEEK-OPTIMA HA Enhanced from Invibio.
The implant is a spinal intervertebral body fusion device that helps stabilize the cervical spine, intended for intervertebral body fusion of the spine of adult patients, using autogenous bone graft to facilitate fusion. The device is indicated for use in patients with degenerative disc disease of the cervical spine at one disc level from the C2-C3 disc to the C7-T1 disc.
More articles on devices:
24 spine devices receive FDA 510(k) clearance in October
Centinel Spine to launch Ti-ACTIVE titanium coating
SI-BONE to host SI joint disorder symposium at NASS meeting